#132: "Real-world" analysis: New anticoagulants better than warfarin in AF; PTCA pioneer passes away: Dr Geoffrey Hartzler; Florida stem-cell cardiologist has license suspended; Dabigatran cost-effective vs warfarin; theheart.org's statin safety survey
"Real-world" analysis: New anticoagulants better than warfarin in AF; PTCA pioneer passes away: Dr Geoffrey Hartzler; Florida stem-cell cardiologist has license suspended; Dabigatran cost-effective vs warfarin; theheart.org's statin safety survey
Source: Radio TheHeart.org - Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
More News: Angioplasty | Cardiology | Cholesterol | Coronary Angioplasty | Coumadin | Heart | Statin Therapy | Stem Cell Therapy | Stem Cells | Warfarin